You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
26 October 2023
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS)
3 February 2022
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
4 February 2021
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)
29 October 2020
24 August 2020
Takeda Pharmaceutical Company Limited: Takeda to Divest its Japan Consumer Health Care Business Unit to Blackstone for JPY 242.0 Billion
31 July 2020
4 February 2020
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)
31 October 2019
6 September 2019
Takeda Pharmaceutical Company Limited: Takeda Issues US Recall of NATPARA(R) (parathyroid hormone) for Injection Due to the Potential for Rubber Particulate
31 July 2019
Takeda Pharmaceutical Company Limited: Takeda Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year
25 April 2019
Takeda Pharmaceutical Company Limited: Revised Forecast of Consolidated Financials for FY2018 (IFRS)
